Valuation: BioNTech SE

Market Cap 2TCr 2.29TCr 1.85TCr 1.71TCr 3.21TCr 2,19600Cr 3.27TCr 22TCr 8.64TCr 1,07500Cr 8.59TCr 8.4TCr 3,70200Cr P/E 2026 *
-18x
P/E 2027 * -17.7x
Enterprise Value 912.36Cr 1.04TCr 843.41Cr 779.22Cr 1.47TCr 1,00300Cr 1.49TCr 10TCr 3.95TCr 49TCr 3.92TCr 3.83TCr 1,69100Cr EV / Sales 2026 *
4.21x
EV / Sales 2027 * 4.79x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+0.37%
1 week-4.13%
Current month-2.85%
1 month-0.15%
3 months-8.14%
6 months-17.16%
Current year-5.04%
1 week 88.35
Extreme 88.35
94.62
1 month 88.35
Extreme 88.35
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
12/05Free

General Counsel

22,655 0.0094%
12/05Free

Executive/Senior Manager

22,655 0.0094%
12/05Free

Chief Operating Officer

22,655 0.0094%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%-4.13%-18.56%-16.48% 2.29TCr
+0.21%-6.28%+56.18%+127.90% 5.45TCr
+6.05%+7.79%+62.23%+88.46% 5.59TCr
+0.89%-2.42%+8.07%+434.51% 2.39TCr
+5.39%+12.90%+47.47%-1.44% 2TCr
-2.29%-1.92%+35.57%-29.14% 1.75TCr
-4.00%-10.96%+181.91%+328.17% 1.54TCr
+10.90%+15.25%+54.50%+745.45% 1.52TCr
-0.48%-2.30%+22.36%+187.62% 1.4TCr
+1.10%-1.56%+67.84%+137.79% 1.24TCr
Average +1.81%-1.80%+51.76%+200.28% 2.52TCr
Weighted average by Cap. +2.22%-0.55%+50.32%+167.26%

Financials

2026 *2027 *
Net sales 216.79Cr 248.08Cr 200.41Cr 185.16Cr 348.68Cr 24TCr 355Cr 2.39TCr 937.71Cr 12TCr 931.83Cr 911.24Cr 40TCr 223.07Cr 255.26Cr 206.22Cr 190.52Cr 358.78Cr 25TCr 365.28Cr 2.46TCr 964.87Cr 12TCr 958.82Cr 937.63Cr 41TCr
Net income -104.89Cr -120.02Cr -97Cr -90Cr -168.7Cr -12TCr -171.75Cr -1.16TCr -453.68Cr -5.65TCr -450.83Cr -440.87Cr -19TCr -116.46Cr -133.27Cr -107.66Cr -99Cr -187.32Cr -13TCr -190.71Cr -1.28TCr -503.75Cr -6.27TCr -500.59Cr -489.53Cr -22TCr
Net Debt -1.09TCr -1.24TCr -1TCr -927.04Cr -1.75TCr -1,19300Cr -1.78TCr -12TCr -4.69TCr -58TCr -4.67TCr -4.56TCr -2,01200Cr -928.56Cr -1.06TCr -858.39Cr -793.05Cr -1.49TCr -1,02100Cr -1.52TCr -10TCr -4.02TCr -50TCr -3.99TCr -3.9TCr -1,72100Cr
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
14/26/14 $90.40 +0.37% 9,23,470
13/26/13 $90.07 -1.55% 6,71,508
10/26/10 $91.49 -1.60% 5,51,755
09/26/09 $92.98 -0.59% 8,16,162
08/26/08 $93.53 -0.81% 6,86,516
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
79.00EUR
Average target price
106.79EUR
Spread / Average Target
+35.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock